west virginia glp-1 nausea law office patients are left in limbo over changing insurance coverage of obesity medications West Virginia patients are left

GLP-1s slow down gastric emptying, which means food stays in your stomach longerhelping you feel full, but also potentially causing bloating or discomfort

But only if they see it coming

It belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists

Improved blood sugar regulation and metabolic health

Currently, there are more than 1 billion people worldwide with obesity, many of whom also have type 2 diabetes mellitus or prediabetes

However, because glucagon-like peptide-1 receptor agonists work to slow gastric emptying, a safety concern has been raised in patients undergoing deep sedation or general anesthesia regarding gastric aspiration, and considering their long half-life in the blood, they are difficult to manage in the perioperative period